MXPA03002122A - Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria. - Google Patents

Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria.

Info

Publication number
MXPA03002122A
MXPA03002122A MXPA03002122A MXPA03002122A MXPA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A
Authority
MX
Mexico
Prior art keywords
agent
inhibiting
inhibition
decrease
methods
Prior art date
Application number
MXPA03002122A
Other languages
English (en)
Inventor
A Johnson Juanita
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03002122A publication Critical patent/MXPA03002122A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Esta invencion se relaciona con un metodo para inhibir una disminucion en el flujo transdermico de un agente que esta siendo suministrado o muestreado transdermicamente durante un periodo prolongado, en donde el suministro o muestreo involucra la ruptura de por lo menos la capa cornea de la piel para formar rutas a traves de las cuales pasa el agente; el resultado deseado se logra al cosuministrar o comuestrear el agente con una cantidad de por lo menos un agente anticicatrizacion, en donde la cantidad del agente anticicatrizacion es efectiva para inhibir una disminucion en el flujo transdermico del agente comparado con el suministro o muestreo del agente bajo condiciones substancialmente identicas, excepto en la ausencia del (los) agente(s) anticicatrizacion.
MXPA03002122A 2000-09-08 2001-09-06 Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria. MXPA03002122A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (en) 2000-09-08 2001-09-06 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure

Publications (1)

Publication Number Publication Date
MXPA03002122A true MXPA03002122A (es) 2004-09-10

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002122A MXPA03002122A (es) 2000-09-08 2001-09-06 Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria.

Country Status (24)

Country Link
US (1) US7438926B2 (es)
EP (1) EP1335711B1 (es)
JP (2) JP5507030B2 (es)
KR (1) KR100764699B1 (es)
CN (1) CN100421653C (es)
AT (1) ATE367805T1 (es)
AU (2) AU8877401A (es)
BR (1) BR0113749A (es)
CA (1) CA2422200A1 (es)
CZ (1) CZ2003687A3 (es)
DE (1) DE60129585T2 (es)
DK (1) DK1335711T3 (es)
EE (1) EE200300095A (es)
ES (1) ES2290166T3 (es)
IL (1) IL154811A0 (es)
MA (1) MA25958A1 (es)
MX (1) MXPA03002122A (es)
NO (1) NO20031071L (es)
NZ (1) NZ524646A (es)
PL (1) PL365603A1 (es)
PT (1) PT1335711E (es)
RU (1) RU2272618C2 (es)
WO (1) WO2002019985A2 (es)
ZA (1) ZA200302700B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524646A (en) * 2000-09-08 2004-10-29 Alza Corp Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
ATE428466T1 (de) * 2000-10-26 2009-05-15 Alza Corp Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
CA2530531A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
AR044985A1 (es) * 2003-07-02 2005-10-12 Alza Corp Metodo y parche de inmunizacion por disposicion de microproyeccion
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
WO2005042702A2 (en) * 2003-10-23 2005-05-12 Alza Corporation Compositions of stabilized dna for coating microprojections
JP2007510445A (ja) 2003-10-24 2007-04-26 アルザ・コーポレーシヨン 経皮薬剤送達促進用の前処置法及びシステム
EP1682012A4 (en) * 2003-11-13 2008-09-24 Alza Corp COMPOSITION AND APPARATUS FOR TRANSDERMAL DELIVERY
WO2005099751A2 (en) 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
CN101027045A (zh) * 2004-04-13 2007-08-29 阿尔扎公司 基于芬太尼药物的透皮释放装置和方法
KR20070011481A (ko) * 2004-04-13 2007-01-24 알자 코포레이션 다중 백신의 경피 전달용 기구 및 방법
CA2576852A1 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
JP5015787B2 (ja) 2004-11-18 2012-08-29 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルアレイの接触コーティング法
KR101224257B1 (ko) * 2004-11-18 2013-01-18 쓰리엠 이노베이티브 프로퍼티즈 컴파니 마이크로니들 어레이를 코팅하기 위한 마스킹 방법
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
AU2006214236A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
US20060253078A1 (en) * 2005-04-25 2006-11-09 Wu Jeffrey M Method of treating skin disorders with stratum corneum piercing device
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
EP1904158B1 (en) * 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
WO2007061964A1 (en) * 2005-11-18 2007-05-31 3M Innovative Properties Company Methods for coating microneedles
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
JPWO2011010456A1 (ja) * 2009-07-24 2012-12-27 株式会社ネクスト２１ ＮＳＡＩＤｓ含有外用剤及び当該外用剤の製造方法
EP2818159A1 (de) * 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
DE59505328D1 (de) * 1994-12-09 1999-04-15 Novartis Ag Transdermales system
AU5740496A (en) 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
WO1996037256A1 (en) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
DE19525607A1 (de) 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
US6230051B1 (en) * 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
DE69722414T2 (de) 1996-07-03 2004-05-19 Altea Therapeutics Corp. Mehrfache mechanische mikroperforierung von haut oder schleimhäuten
US5983136A (en) 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
CN1133472C (zh) 1996-12-20 2004-01-07 阿尔萨公司 增加经皮样剂流量的装置
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
DK1314400T3 (da) * 1996-12-31 2007-10-15 Altea Therapeutics Corp Mikroporering af væv til levering af bioaktive midler
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
JP2001525227A (ja) * 1997-12-11 2001-12-11 アルザ・コーポレーション 経皮的薬剤流量を高めるための装置
DK1037686T3 (da) * 1997-12-11 2006-01-02 Alza Corp Apparat til forögelse af transdermal gennemströmning af midler
ATE221400T1 (de) * 1997-12-11 2002-08-15 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
WO1999064580A1 (en) 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
CA2372919A1 (en) * 1999-05-17 2000-11-23 Kevin S. Machitto Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
CA2376128C (en) * 1999-06-04 2009-01-06 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
ATE295200T1 (de) * 1999-12-10 2005-05-15 Alza Corp Hautbehandlungsvorrichtung zur verlängerten transdermalen verabreichung von medikamenten
EP1239916B1 (en) * 1999-12-10 2005-11-23 ALZA Corporation Device and method for enhancing microprotrusion skin piercing
NZ524646A (en) * 2000-09-08 2004-10-29 Alza Corp Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
ATE428466T1 (de) * 2000-10-26 2009-05-15 Alza Corp Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US20040115167A1 (en) * 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
EE200300095A (et) 2005-02-15
NO20031071D0 (no) 2003-03-07
BR0113749A (pt) 2004-06-22
CA2422200A1 (en) 2002-03-14
PT1335711E (pt) 2007-09-05
DK1335711T3 (da) 2007-11-26
EP1335711B1 (en) 2007-07-25
ES2290166T3 (es) 2008-02-16
ATE367805T1 (de) 2007-08-15
JP5507030B2 (ja) 2014-05-28
MA25958A1 (fr) 2003-12-31
PL365603A1 (en) 2005-01-10
NO20031071L (no) 2003-05-06
WO2002019985A2 (en) 2002-03-14
KR20030074595A (ko) 2003-09-19
DE60129585D1 (de) 2007-09-06
US7438926B2 (en) 2008-10-21
CN1473037A (zh) 2004-02-04
AU2001288774B2 (en) 2006-06-29
DE60129585T2 (de) 2008-04-17
JP2013256500A (ja) 2013-12-26
WO2002019985A3 (en) 2002-09-06
EP1335711A2 (en) 2003-08-20
JP2004508319A (ja) 2004-03-18
ZA200302700B (en) 2004-08-13
CZ2003687A3 (cs) 2004-01-14
AU8877401A (en) 2002-03-22
NZ524646A (en) 2004-10-29
RU2272618C2 (ru) 2006-03-27
CN100421653C (zh) 2008-10-01
US20020102292A1 (en) 2002-08-01
KR100764699B1 (ko) 2007-10-08
IL154811A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
AU8877401A (en) Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
WO2004006906A3 (en) Methods for the treatment of neoplasms
HK1068545A1 (en) Transdermal patch for administering fentanyl
WO2006047392A3 (en) Nicotinic-opioid synergy for analgesia
IE893455L (en) Dosage form having reduced abuse potential
EP1418976A4 (en) DEVICES AND METHODS FOR THE TITRATION OF MEDICINAL RELEASE
WO2003032914A3 (en) Methods for treating substance abuse with cholinesterase inhibitors
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
WO2005018677A3 (en) Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
MXPA05003501A (es) Metodos para tratamiento del dolor administrando un antagonista del factor de crecimiento del nervio y un analgesico opioide y composiciones que los contienen.
AU4743601A (en) Neutral antagonists and use thereof in treating drug abuse
MX2007005065A (es) Forma de dosis de tiempo de retraso de farmacos para la terapia de insomnio.
AU2002241736A1 (en) Method for preventing or treating pain by administering an endothelin antagonist
TW200605929A (en) Method and apparatus for reducing the incidence of tobacco use
WO2001068125A3 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
DE60112248D1 (de) Allzweck -medikament und -wärmebehandlungssystem
WO2001087343A3 (en) Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
WO2007143185A3 (en) Transdermal treatment of tendinopathy using glyceryl trinitrite
EP1108426A3 (en) Use of prostaglandin agonists to treat erectile dysfunction or impotence
EP1441718A4 (en) CARBINOL FOR THE TREATMENT OF NEUROPATHIC FUNCTIONAL DISORDER
TW200633720A (en) Medicinal composition for diabetic
AU1345000A (en) Irrigation solution and method for inhibition of pain and inflammation
WO2001000191A3 (en) Use of fosphenytion for the treatment of acute neuropathic pain
IL141117A0 (en) Means for retaining transcutaneous catheters and needles in place

Legal Events

Date Code Title Description
FG Grant or registration